Inflammatory processes in Kawasaki disease reach their peak at the sixth day of fever onset: Laboratory profiles according to duration of fever

Journal of Korean Medical Science

Volumn 19, Issue 4, 2004, Pages 501-504

  Lee, Kyung Yil ^a,b   Han, Ji Whan ^a   Hong, Ja Hyun ^a   Lee, Hyung Shin ^a   Lee, Joon Sung ^a   Kyung Tai Whang, ^a  

^a The Catholic University of Korea   (South Korea)

^b Daejeon St Mary's Hospital   (South Korea)

Author keywords

C Reactive Protein; Immunoglobulins Intravenous; Inflammation; Kawasaki Disease; Leukocytes; Mucocutaneous Lymph Node Syndrome

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN;

ARTERY LESION; ARTICLE; CHILD; CONTROLLED STUDY; CORONARY ARTERY; EVALUATION; FEMALE; FEVER; HEMATOLOGY; HUMAN; INFANT; INFLAMMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROTEIN ANALYSIS; SINGLE DRUG DOSE;

EID: 4444325698     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2004.19.4.501     Document Type: Article

References (20)

1. Kawasaki T. Acute, febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy (Arerugi) 1967; 16: 178-222.
2. Sundel RP, Newberger JW. Kawasaki disease. Curr Opin Infect Dis 1992; 5: 664-9.
3. Rowley AH, Gonzalez-Crussi F, Shulman ST. Kawasaki syndrome. Rev Infect Dis 1988; 10: 1-15.
4. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DY. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc Natl Acad Sci USA 1992; 89: 4066-70.
5. Lee KY, Lee HS, Hong JH, Han JW, Lee JS, Whang KT. High-dose intravenous immunoglobulin down-regulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki disease. J Trop Pediatr 2004; in press.
6. Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T. High dose intravenous gamma globulin for Kawasaki disease. Lancet 1984; 2: 1055-8.
7. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of Kawasaki syndrome. N Engl J Med 1991; 324: 1633-9.
8. Hicks RV, Melish ME. Kawasaki syndrome; Rheumatic complains and analysis of salicylate therapy. Arthritis Rheum 1979; 22: 621-2.
9. Japan Kawasaki Disease Research Committee. Diagnostic guidelines of Kawasaki disease. 4th ed. Tokyo: Japan Kawasaki Disease Research Committee, 1984.
10. Kushner I. C-reactive protein and the acute-phase response. Hosp Pract 1990; 25: 21-8.
11. Sammalkorpi K, Valtonen V, Kerttula Y, Nikkila E, Taskinen MR. Changes in serum lipoprotein pattern induced by acute infection. Metabolism 1988; 37: 859-65.
12. Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid profile after Kawasaki syndrome. Circulation 1991; 84: 625-31.
13. Nomura Y, Masuda K, Yoshinaga M, Sameshima K, Miyata K. Patients diagnosed with Kawasaki disease before the fifth day of illness have a high risk of coronary artery aneurysm. Pediatr Intern 2002; 44: 353-7.
14. Tse SML, Silverman ED, McCrindle BW, Yeung RSM. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr 2002; 140: 450-5.
15. Koren G, Lavi S, Rose V, Rowe R: Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 1986; 108: 388-92.
16. Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW. A predictive instrument for coronary artery aneurysms in Kawasaki disease. Am J Cardiol 1998; 81: 1116-20.
17. Koyanagi H, Nakamura Y, Yanagawa H. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease. Acta Paediatr 1998; 87: 32-6.
18. Lee KY, Han JW, Lee JS, Whang KT. Alteration of biochemical profiles after high-dose intravenous immunoglobulin administration in Kawasaki disease. Acta Paediatr 2002; 91: 164-7.
19. Lee GB, Lee JW, Lee KY. Prediction of intravenous immunoglobulin non-responders in patients with Kawasaki disease. Korean J Pediatr 2004; 47: 90-4.
20. Lee KY, Han JW, Lee HS, Hong JH, Hahn SH, Lee JS, Whang KT. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000). Pediatr Infect Dis J 2004; 23: 52-5.